These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 39364436)

  • 1. Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(9):1-293. PubMed ID: 39364436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homologous Recombination Deficiency Testing to Inform Patient Decisions About Niraparib Maintenance Therapy for High-Grade Serous or Endometrioid Epithelial Ovarian Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(5):1-188. PubMed ID: 37637244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density.
    Stout NK; Miglioretti DL; Su YR; Lee CI; Abraham L; Alagoz O; de Koning HJ; Hampton JM; Henderson L; Lowry KP; Mandelblatt JS; Onega T; Schechter CB; Sprague BL; Stein S; Trentham-Dietz A; van Ravesteyn NT; Wernli KJ; Kerlikowske K; Tosteson ANA
    JAMA Intern Med; 2024 Oct; 184(10):1222-1231. PubMed ID: 39186304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(10):1-234. PubMed ID: 32284770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
    Glechner A; Wagner G; Mitus JW; Teufer B; Klerings I; Böck N; Grillich L; Berzaczy D; Helbich TH; Gartlehner G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009632. PubMed ID: 36999589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(7):1-165. PubMed ID: 34211616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(3):1-55. PubMed ID: 23074406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.
    Ontario Health
    Ont Health Technol Assess Ser; 2024; 24(2):1-162. PubMed ID: 38344326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(15):1-160. PubMed ID: 33240456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermediate breast cancer risk in US healthcare.
    Blankenburg M; Sánchez-Collado I; Soyemi BO; Åkerborg Ö; Caleyachetty A; Harris J; Morris E; Newstead G; Lobig F
    J Med Econ; 2023; 26(1):850-861. PubMed ID: 37278659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(15):1-71. PubMed ID: 27468326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(14):1-148. PubMed ID: 33240455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional Exhaled Nitric Oxide Testing for the Diagnosis and Management of Asthma: a Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2024; 24(5):1-225. PubMed ID: 39329005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.